Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies.
Nausicaa ClementeBenedetta FerraraCasimiro Luca GigliottiElena BoggioMaria Teresa CapucchioElena BiasibettiDavide SchifferMarta MellaiLaura AnnovazziLuigi CangemiElisabetta MuntoniGianluca MiglioUmberto DianzaniLuigi BattagliaChiara DianzaniPublished in: International journal of molecular sciences (2018)
SLN could be a promising strategy for the delivery of TMZ, allowing an increased stability of the drug and thereby its employment in the treatment of aggressive malignacies.